Literature DB >> 16086395

Mutation analysis of the HDAC 1, 2, 8 and CDKL5 genes in Rett syndrome patients without mutations in MECP2.

Peter Huppke1, Andreas Ohlenbusch, Cornelia Brendel, Franco Laccone, Jutta Gärtner.   

Abstract

Mutations in the MECP2 gene are found in only 80% of patients with Rett syndrome (RTT). Therefore other genes have to be involved in the pathogenesis of RTT. By using our defined diagnostic criteria we first re-evaluated 50 girls with possible RTT in whom the sequencing of the MECP2 gene had not revealed any mutations. Only 15 of theses patients fulfilled all criteria for RTT and could be considered to have classical RTT. In eight of these, further molecular analyses revealed large deletions of the MECP2 gene. In the remaining seven girls we then analyzed the genes HDAC1, HDAC2, and HDAC8 that encode for the histone deacetylases 1, 2, and 8 which interact with MeCP2 and are essential for its function. Although these histone deacetylase genes have been considered as good candidate genes for RTT our molecular analysis of these genes did not detect any mutations. Because recently mutations in CDKL5 were reported in patients with RTT, we included this gene in our analysis but failed to detect any mutations. We conclude that only a subgroup of girls with possible RTT and no detectable mutation in the sequencing of the MECP2 gene do really have classical RTT. In many of those large MECP2 gene deletions can be detected by further analysis. The genes HDAC1, HDAC2, and HDAC8 do not seem to play a role in the pathogenesis of RTT and at least in our subgroup no mutations in the CDKL5 gene were detected. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086395     DOI: 10.1002/ajmg.a.30764

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients.

Authors:  H L Archer; S D Whatley; J C Evans; D Ravine; P Huppke; A Kerr; D Bunyan; B Kerr; E Sweeney; S J Davies; W Reardon; J Horn; K D MacDermot; R A Smith; A Magee; A Donaldson; Y Crow; G Hermon; Z Miedzybrodzka; D N Cooper; L Lazarou; R Butler; J Sampson; D T Pilz; F Laccone; A J Clarke
Journal:  J Med Genet       Date:  2005-09-23       Impact factor: 6.318

Review 2.  Rett syndrome and MeCP2.

Authors:  Vichithra R B Liyanage; Mojgan Rastegar
Journal:  Neuromolecular Med       Date:  2014-03-11       Impact factor: 3.843

3.  When Rett syndrome is due to genes other than MECP2.

Authors:  Alan K Percy; Jane Lane; Fran Annese; Hannah Warren; Steven A Skinner; Jeffrey L Neul
Journal:  Transl Sci Rare Dis       Date:  2018-04-13

4.  A kinome-wide screen identifies a CDKL5-SOX9 regulatory axis in epithelial cell death and kidney injury.

Authors:  Ji Young Kim; Yuntao Bai; Laura A Jayne; Ralph D Hector; Avinash K Persaud; Su Sien Ong; Shreshtha Rojesh; Radhika Raj; Mei Ji He Ho Feng; Sangwoon Chung; Rachel E Cianciolo; John W Christman; Moray J Campbell; David S Gardner; Sharyn D Baker; Alex Sparreboom; Rajgopal Govindarajan; Harpreet Singh; Taosheng Chen; Ming Poi; Katalin Susztak; Stuart R Cobb; Navjot Singh Pabla
Journal:  Nat Commun       Date:  2020-04-21       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.